Dr. Firhan Malik (Ph.D.‘ 2014, U of T) currently works as a Management Consultant at Qral Group, a US-based healthcare consulting firm. At Qral Group, Firhan works with private and public biotechnology and pharmaceutical companies on projects ranging from competitive intelligence to market research to commercial operations. His projects have hit the spectrum of traditional pharmaceuticals through leading-edge novel therapeutics, like cell and gene therapy. Prior to Qral Group, Firhan worked with early-stage life sciences companies, serving in advisory roles and investor discussions. Firhan has also led scientific due diligence and helped pharmaceutical clients complete acquisition and licensing deals at a Toronto-based boutique healthcare consulting firm. Firhan has over 10+ years of experience in academic research, and conducted his graduate student research in the University of Toronto’s Faculty of Medicine. He primarily studied cystic fibrosis, a rare genetic disease, and congestive heart failure in the renowned medical research institutions the Hospital for Sick Children, the Heart and Stroke Richard Lewar Center in Excellence, and the MaRS Discovery District. Firhan has extensive knowledge in the use of novel therapeutics (e.g., orphan drugs) in cell models and the scale-up of these therapeutics into animal models. Before coming to Toronto, he was the lead investigator of a large-scale Northern Ontario human health study that assessed the relationships between heavy metal concentrations in human hair samples, the environment, nutrition, and chronic diseases. Firhan was featured on the CBC for his work on this important research. Firhan received his BSc. (Honours) in Biochemistry from Laurentian University, and his MSc. in Biochemistry and his Ph.D. in Physiology at the University of Toronto. His work has been funded by the Natural Sciences and Engineering Research Council (NSERC) of Canada.